Immunic, Inc.
(NASDAQ : IMUX)

( )
IMUX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
3.06%134.970.7%$1080.35m
BMYBristol-Myers Squibb Co.
0.14%58.591.4%$769.26m
MRKMerck & Co., Inc.
0.41%84.900.7%$739.57m
ABBVAbbVie, Inc.
1.13%88.622.3%$703.24m
PFEPfizer Inc.
2.00%37.280.9%$692.31m
LLYEli Lilly & Co.
1.61%113.181.1%$381.20m
NVSNovartis AG
0.59%90.040.2%$155.54m
RETAReata Pharmaceuticals, Inc.
-2.23%198.913.8%$154.38m
AZNAstraZeneca Plc
0.17%47.451.2%$147.59m
GSKGlaxoSmithKline Plc
0.57%44.100.2%$120.53m
NVONovo Nordisk A/S
-1.05%57.280.1%$73.92m
SNYSanofi
2.42%46.110.2%$61.20m
RARXRa Pharmaceuticals, Inc.
0.32%46.750.8%$43.76m
CNSTConstellation Pharmaceuticals, Inc.
1.48%38.480.0%$30.56m
GRFSGrifols SA
0.19%21.690.7%$24.63m

Company Profile

Immunic, Inc. engages in developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.